Second generation antipsychotics in ‘real-life’ paediatric patients. Adverse drug reactions and clinical outcomes of drug switch
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Second generation antipsychotics in ‘real-life’ paediatric patients. Adverse drug reactions and clinical outcomes of drug switch
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 15, Issue sup2, Pages 1-8
Publisher
Informa UK Limited
Online
2016-11-23
DOI
10.1080/14740338.2016.1229301
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ten Years of Antipsychotic Prescribing to Children: A Canadian Population-Based Study
- (2017) Silvia Alessi-Severini et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism
- (2015) Andrea de Bartolomeis et al. CNS DRUGS
- Type 2 Diabetes in Children and Adolescents on Atypical Antipsychotics
- (2015) Pornpoj Pramyothin et al. Current Diabetes Reports
- Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends
- (2015) Louise Carton et al. CURRENT PHARMACEUTICAL DESIGN
- Antipsychotic prescribing in youths: a French community-based study from 2006 to 2013
- (2015) Hélène Verdoux et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings
- (2015) Marco Pozzi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Child and Adolescent Psychiatrists' Reported Monitoring Behaviors for Second-Generation Antipsychotics
- (2015) Angie Mae Rodday et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Therapeutic Drug Levels of Second Generation Antipsychotics in Youth: A Systematic Review
- (2015) Zachary Whitney et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Trends in Atypical Antipsychotics Prescribed to Children Six Years of Age or Less on Medicaid in Kentucky
- (2015) W. David Lohr et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology
- (2015) Leonel E. Rojo et al. PHARMACOLOGICAL RESEARCH
- Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial
- (2015) Jingyuan Zhao et al. PLoS One
- Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose–response study
- (2015) Jing-Xu Chen et al. PSYCHONEUROENDOCRINOLOGY
- Risk for Incident Diabetes Mellitus Following Initiation of Second-Generation Antipsychotics Among Medicaid-Enrolled Youths
- (2015) David M. Rubin et al. JAMA Pediatrics
- Treatment of Young People With Antipsychotic Medications in the United States
- (2015) Mark Olfson et al. JAMA Psychiatry
- The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review
- (2014) J. Peuskens et al. CNS DRUGS
- Second Generation Antipsychotics in Adolescent Anorexia Nervosa: A New Hypothesis of Eligibility Criteria
- (2014) Simone Pisano et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Massive Asymptomatic Creatine Kinase Elevation in Youth During Antipsychotic Drug Treatment: Case Reports and Critical Review of the Literature
- (2014) Gabriele Masi et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Lack of Effect of Risperidone on Core Autistic Symptoms: Data from a Longitudinal Study
- (2014) Natasha Marrus et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Body Mass Index Change in Autism Spectrum Disorders: Comparison of Treatment with Risperidone and Aripiprazole
- (2014) Logan K. Wink et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Antipsychotic Use in Children and Adolescents
- (2014) Inmaculada Baeza et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Effectiveness and Tolerability of Switching to Aripiprazole From Risperidone in Subjects With Autism Spectrum Disorders
- (2013) Makoto Ishitobi et al. CLINICAL NEUROPHARMACOLOGY
- Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches
- (2013) Carla Carnovale et al. EUROPEAN JOURNAL OF PEDIATRICS
- Are Non-Serious Adverse Reactions to Psychiatric Drugs Really Non-Serious?
- (2013) Marco Pozzi et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Controversies in the use of second generation antipsychotics as sleep agent
- (2013) Chintan Shah et al. PHARMACOLOGICAL RESEARCH
- Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders
- (2013) Laura C. Politte et al. PSYCHOPHARMACOLOGY
- Weight Gain and Other Metabolic Adverse Effects Associated with Atypical Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-analysis
- (2013) Noor B. Almandil et al. PEDIATRIC DRUGS
- Safety and Pharmacokinetics of Atypical Antipsychotics in Children and Adolescents
- (2013) Silvio Caccia PEDIATRIC DRUGS
- National Trends in the Mental Health Care of Children, Adolescents, and Adults by Office-Based Physicians
- (2013) Mark Olfson et al. JAMA Psychiatry
- Efficacy and safety of aripiprazole in child and adolescent patients
- (2012) Eiji Kirino EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Antipsychotics in pediatric and adolescent patients: A review of comparative safety data
- (2012) Leila Ben Amor JOURNAL OF AFFECTIVE DISORDERS
- Antipsychotic Medication Prescribing Trends in Children and Adolescents
- (2012) Joyce Nolan Harrison et al. Journal of Pediatric Health Care
- Switching to aripiprazole in subjects with Pervasive Developmental Disorders showing tolerability issues with risperidone
- (2012) Makoto Ishitobi et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Efectos secundarios del tratamiento antipsicótico en niños y adolescentes naïve o quasi-naïve: diseño de un protocolo de seguimiento y resultados basales
- (2012) Jessica Merchán-Naranjo et al. Revista de Psiquiatria y Salud Mental
- Management of Schizophrenia in Children and Adolescents
- (2011) Gabriele Masi et al. DRUGS
- Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders
- (2010) Hanik K. Yoo et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Aripiprazole in autism spectrum disorders and fragile X syndrome
- (2010) Craig A. Erickson et al. Neurotherapeutics
- Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns
- (2009) Benedetto Vitiello et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Sexual Dysfunction in Patients Treated With Atypical Antipsychotics
- (2009) Jonathan M. Meyer JOURNAL OF CLINICAL PSYCHIATRY
- Antipsychotic Use in Children and Adolescents: Minimizing Adverse Effects to Maximize Outcomes
- (2009) CHRISTOPH U. CORRELL et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search